ANDA 90954, held by Genera Pharms. Cromolyn Sodium.
As of Nov 21, 2026, ANDA 90954 (Cromolyn Sodium), held by Genera Pharms, was first approved by FDA on Dec 18, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 18, 2009 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cromolyn Sodium100MG/5ML · concentrate;oral | Cromolyn Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters